Immunovant
IMVT
IMVT
228 hedge funds and large institutions have $2.9B invested in Immunovant in 2023 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 67 increasing their positions, 73 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
8% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 73
3.54% less ownership
Funds ownership: 51.19% → 47.65% (-3.5%)
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Holders
228
Holding in Top 10
9
Calls
$70.2M
Puts
$49.3M
Top Buyers
| 1 | +$112M | |
| 2 | +$37.8M | |
| 3 | +$36.8M | |
| 4 |
Morgan Stanley
New York
|
+$30.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$26.6M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$69.8M | |
| 3 | -$62.6M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$39.1M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$28.8M |